SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-132782
Filing Date
2021-04-27
Accepted
2021-04-27 07:41:30
Documents
5
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A d80529ddef14a.htm DEF 14A 486915
2 GRAPHIC g80529g32w91.jpg GRAPHIC 298986
3 GRAPHIC g80529g62i88.jpg GRAPHIC 306778
4 GRAPHIC g80529g67e73.jpg GRAPHIC 31472
5 GRAPHIC g80529g68e27.jpg GRAPHIC 32792
  Complete submission text file 0001193125-21-132782.txt   1411268
Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Filer) CIK: 0001771917 (see all company filings)

IRS No.: 270605902 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38958 | Film No.: 21855889
SIC: 2834 Pharmaceutical Preparations